SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Aug 12, 2022–
Confluent Medical Technologies (Confluent) today announced the Grand Opening of the newest addition to their large-scale manufacturing center of excellence in Alajuela, Costa Rica, expanding their capacity for Nitinol processing and catheter manufacturing.
This press release contains multimedia. Watch the full release here: https://www.businesswire.com/news/home/20220812005083/en/Read:UK-based PsycApps secures €1.7 million to develop its gamified mental health app
(Photo: Business Wire)
This new facility will be merged with the existing Confluente Costa Rica facility and will add 66,000 square feet to this location. The new site significantly expands Confluent’s capacity to process Nitinol components and manufacture complex catheters using a combination of cleanroom and whitespace manufacturing.
“Confluent has experienced consistent and strong growth in recent years,” said Confluent President & CEO Dean Schauer. “This expansion supports our new product pipeline that continues to grow at a rate greater than Confluent has experienced before.”
Confluent supports some of the fastest growing medical device markets such as Interventional Neurovascular, Electrophysiology, Structural Heart and Peripheral Vascular. As a result of the double-digit growth of these currently served markets, a significant number of new products are entering production that will immediately utilize this new facility space. In addition, Confluent is considering additional expansion options outside of this new facility.
About Confluent Medical TechnologiesRead:All About Better by Bike, the Cycling Project Aiming to Boost Our Mental and Physical Wellbeing
Confluent applies materials science to MedTech innovation. Confluent’s developed solutions to the most challenging design problems enable our medical device OEM customers to offer life-saving implantable products. Our customers rely on Confluent for materials science and associated manufacturing expertise critical to the function and value of their most demanding, high-growth products – patented expertise that includes high purity Nitinol processing, ultra-high density knitting of biomedical textiles and precision laser treatment of special polymers. Confluent partners with leading OEMs to create a selective product portfolio that spans complex applications such as transcatheter heart valves, neurovascular implants, endovascular stent grafts and advanced smart catheters. With facilities in Fremont and Laguna Niguel, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; and San Jose, Costa Rica, Confluent has earned the trust of leaders in the medical device community through a proven track record of innovative materials science, engineering and manufacturing.Read:Imaging vendor enters genetic medicine IT arena
For information, contact Confluent Medical, https://confluentmedical.com/.
Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20220812005083/en/
Brittany Mai, [email protected]
KEY WORD: ARIZONA COSTA RICA UNITED STATES CENTRAL AMERICA NORTH AMERICA
INDUSTRY KEYWORD: TECHNOLOGY MEDICAL DEVICES NEUROLOGY ENGINEERING OTHER TECHNOLOGY HEALTH TECHNOLOGY MANUFACTURING CARDIOLOGY HEALTH
SOURCE: Confluent Medical Technologies
Copyright Business Wire 2022.
PUB: 08/12/2022 10:15 AM/DISC: 08/12/2022 10:16 AM
Copyright Business Wire 2022.